A cost-effectiveness analysis of adjuvant therapies for resected adenocarcinoma of the rectum.

被引：0
|
作者：
Lee, JH [1 ]
机构：
[1] UNIV PENN,SCH MED,DIV GEN INTERNAL MED,PHILADELPHIA,PA 19104
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 39卷 / 02期
关键词：
D O I：
10.1016/S0360-3016(97)80759-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [31] Decoding cost-effectiveness of PNH therapies
    Kelkar, Amar H.
    Abel, Gregory A.
    BLOOD, 2025, 145 (01) : 8 - 10
  • [32] Cost-effectiveness analysis of adjuvant treatments in the management of breast cancer
    Selke, B
    Lenne, X
    Bercez, C
    Bonneterre, ME
    Lebrun, T
    Bonneterre, J
    MEDICAL DECISION MAKING, 1998, 18 (04) : 488 - 488
  • [33] Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis
    Zhang, Mengxi
    Wen, Feng
    He, Xiaofeng
    Zhang, Weihan
    Hu, Jiankun
    Li, Qiu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [34] Field therapies for actinic keratosis: an Australian cost-effectiveness analysis
    Gu, Yaron
    Shah, Kinar Mistry
    Li, Grace Xiaoying
    Sebaratnam, Deshan Frank
    Sun, Helen Yiling
    JEADV CLINICAL PRACTICE, 2025, 4 (01): : 137 - 144
  • [35] Cost-effectiveness analysis of cholesterol-lowering therapies in Spain
    Plans-Rubió P.
    American Journal of Cardiovascular Drugs, 2006, 6 (3) : 177 - 188
  • [36] COST-EFFECTIVENESS ANALYSIS OF BIOLOGIC THERAPIES FOR TREATMENT OF PSORIATIC ARTHRITIS
    Gharaibeh, M.
    Folse, H. J.
    Stolshek, B.
    Zou, D.
    Harris, M.
    Collier, D.
    Malone, D. C.
    VALUE IN HEALTH, 2018, 21 : S196 - S197
  • [37] ASSESSING THE COST-EFFECTIVENESS OF ADJUVANT THERAPIES IN EARLY BREAST-CANCER USING A DECISION-ANALYSIS MODEL
    HILLNER, BE
    SMITH, TJ
    DESCH, CE
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 25 (02) : 97 - 105
  • [38] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [39] Cost-effectiveness of adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for curatively resected gastric cancer
    Hisashige, A.
    Sasako, M.
    Nakajima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer
    Hisashige, A.
    Yoshida, S.
    Kodaira, S.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1232 - 1238
12345